Dupixent 300 MG/2 ML pen 2ML
Ended Awarded
- Contract number
- SPE2DB25FY9PP
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $87,464
Award facts
- Contract value 100% obligated
- $87,463.65 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $87,463.65 to AmerisourceBergen Drug Corp for the supply of Dupixent 300 mg/2 ml pen injectors on August 19, 2025, with an ultimate completion date of August 20, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999.99 million through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal vendor specializing in medical procurement for military and veteran healthcare systems. As a child contract action under the SPE2DX IDC, this delivery order exemplifies the company's role in supplying brand-name medications and specialty pharmaceuticals to support Defense Health Agency and other federal healthcare customers globally. Dupixent is a prescription biologic medication commonly used to treat moderate-to-severe eczema, asthma, and other inflammatory conditions, making this procurement consistent with the company's extensive portfolio of specialty medications and therapeutics delivered through the DLA supply chain.
Quick answers
Who was awarded contract SPE2DB25FY9PP?
SPE2DB25FY9PP was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 19, 2025.
How much is contract SPE2DB25FY9PP worth?
The government has obligated $87,464 on SPE2DB25FY9PP.
Is contract SPE2DB25FY9PP an order under another contract?
Yes. SPE2DB25FY9PP is a delivery order under SPE2DB22D3301, an indefinite delivery contract.
Was contract SPE2DB25FY9PP competed?
The extent of competition for SPE2DB25FY9PP was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award